Total amount raised
$133 Million
Latest funding date
7/1/2022
Location
Syapse has successfully raised significant funding over multiple rounds, attracting a diverse group of investors. The company focuses on providing precision medicine solutions to improve patient outcomes.
What Is Syapse?
Syapse, founded in 2008, is headquartered in San Francisco, California. The company specializes in precision medicine, aiming to improve patient outcomes through data-driven insights.
Founded by Jonathan Hirsch and Eric Schadt, Syapse has grown significantly over the years. The company leverages real-world data to support healthcare providers in delivering personalized care.
With a dedicated team of over 100 employees, Syapse continues to innovate in the field of precision medicine. Their solutions are designed to integrate seamlessly into existing healthcare systems, enhancing the quality of care for patients worldwide.
How Much Funding Has Syapse Raised?
- Series D
- Amount Raised: $30 million
- Date: November 2017
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand operations and bring Syapse's solutions to more providers and their cancer patients.
- Growth Equity Round
- Amount Raised: $68 million
- Date: February 2021
- Lead Investors: Ally Bridge Group
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand partnering opportunities with life sciences companies, health systems, regulators and molecular labs.
- Growth Funding Round
- Amount Raised: $35 million
- Date: July 2022
- Lead Investors: Innovatus Capital Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand Syapse's focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer.
Syapse's three disclosed rounds total $133 million. The current valuation is not publicly disclosed.
Key Investors
- Innovatus Capital Partners
- Details: Innovatus Capital Partners is a private investment firm that focuses on creating value through innovative investment strategies. They led the latest funding round for Syapse.
- Investment Focus Areas: Healthcare, real estate, asset-based lending.
- Notable Investments: Not publicly disclosed.
- Ally Bridge Group
- Details: Ally Bridge Group is a global healthcare-focused investment firm. They have a strong track record in investing in innovative healthcare companies.
- Investment Focus Areas: Healthcare, life sciences, medical technology.
- Notable Investments: Not publicly disclosed.
- Merck Global Health Innovation Fund
- Details: Merck Global Health Innovation Fund is the corporate venture capital arm of Merck & Co. They invest in companies that align with Merck's strategic interests.
- Investment Focus Areas: Healthcare innovation, digital health, precision medicine.
- Notable Investments: Not publicly disclosed.
- Northpond Ventures
- Details: Northpond Ventures is a venture capital firm that invests in science and technology companies. They focus on transformative innovations.
- Investment Focus Areas: Life sciences, healthcare, technology.
- Notable Investments: Not publicly disclosed.
- Social Capital
- Details: Social Capital is a venture capital firm that aims to advance humanity by solving the world's hardest problems. They invest in companies that have a significant impact.
- Investment Focus Areas: Technology, healthcare, education.
- Notable Investments: Not publicly disclosed.
What's Next for Syapse?
Syapse stands at the cusp of significant growth opportunities, particularly in the realm of precision oncology. By expanding its focus on providing real-world insights, the company aims to enhance outcomes for cancer patients. Collaborations with community health systems and biopharmaceutical companies are set to drive this mission forward, leveraging data to transform patient care.
N-Power Medicine acquired Syapse in a stock-for-stock exchange completed on December 30, 2024, so Syapse no longer raises funding of its own. Syapse's network and technology now sit inside N-Power Medicine, which said it would use them to widen community access to clinical trials.
However, challenges such as competition in healthcare technology and regulatory hurdles may arise. Integrating real-world data into clinical practice is complex, requiring robust systems and continuous innovation. Despite these challenges, Syapse's strategic partnerships and focus on precision medicine position it well for future success.
Use Clay to Get Funding Data
Sales professionals, take advantage of Clay's platform to access comprehensive fundraising data on companies like Syapse and gather other critical business insights. Sign up for free today and elevate your sales strategy with the power of data-driven insights.
